Proteomic comparison between non‐purified cerebrospinal fluid and cerebrospinal fluid‐derived extracellular vesicles from patients with Alzheimer's, Parkinson's and Lewy body dementia
Journal of Extracellular Vesicles · 2023
DOI: 10.1002/jev2.12383 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, 2023. Verfasst von Yael Hirschberg und 8 weiteren Autor:innen. Beteiligte Einrichtung: Health Unit, Flemish Institute for Technological Research (VITO), Mol, Belgium. Hauptthemen laut MEDLINE: Alzheimer Disease, Lewy Body Disease, Parkinson Disease, Dementia. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Alzheimer's Association, Carlos III Health Institute, Flemish Institute for Technological Research.
Themen: Demenz
Abstract (Originalsprache)
Dementia is a leading cause of death worldwide, with increasing prevalence as global life expectancy increases. The most common neurodegenerative disorders are Alzheimer's disease (AD), dementia with Lewy bodies (DLB) and Parkinson's disease dementia (PDD). With this study, we took an in‐depth look at the proteome of the (non‐purified) cerebrospinal fluid (CSF) and the CSF‐derived extracellular vesicles (EVs) of AD, PD, PD‐MCI (Parkinson's disease with mild cognitive impairment), PDD and DLB patients analysed by label‐free mass spectrometry. This has led to the discovery of differentially expressed proteins that may be helpful for differential diagnosis. We observed a greater number of differentially expressed proteins in CSF‐derived EV samples ( N = 276) compared to non‐purified CSF ( N = 169), with minimal overlap between both datasets. This finding suggests that CSF‐derived EV samples may be more suitable for the discovery phase of a biomarker study, due to the removal of more abundant proteins, resulting in a narrower dynamic range. As disease‐specific markers, we selected a total of 39 biomarker candidates identified in non‐purified CSF, and 37 biomarker candidates across the different diseases under investigation in the CSF‐derived EV data. After further exploration and validation of these proteins, they can be used to further differentiate between the included dementias and may offer new avenues for research into more disease‐specific pharmacological therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Health Unit, Flemish Institute for Technological Research (VITO), Mol, Belgium.
- Centre for Proteomics (CfP), University of Antwerp, Antwerp, Belgium.
- Department of Neurology, Sant Pau Memory Unit, Sant Pau Biomedical Research Institute, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
- Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), Madrid, Spain.
- Department of Neurology and Bru-BRAIN, Universitair Ziekenhuis Brussel and NEUR Research Group, Center for Neurosciences (C4N), Vrije Universiteit Brussel (VUB), Brussels, Belgium.
- Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
ORCID-Profile: Yael Hirschberg, Roosmarijn E Vandenbroucke
Förderung
- Alzheimer's Association
- Carlos III Health Institute
- Flemish Institute for Technological Research
Zitieren
APA
Hirschberg, Y., Valle-Tamayo, N., Dols-Icardo, O., Engelborghs, S., Buelens, B., Vandenbroucke, R. E., Vermeiren, Y., Boonen, K., & Mertens, I. (2023). Proteomic comparison between non‐purified cerebrospinal fluid and cerebrospinal fluid‐derived extracellular vesicles from patients with Alzheimer's, Parkinson's and Lewy body dementia. Journal of Extracellular Vesicles. https://doi.org/10.1002/jev2.12383
Vancouver
Hirschberg Y, Valle-Tamayo N, Dols-Icardo O, Engelborghs S, Buelens B, Vandenbroucke RE, et al. Proteomic comparison between non‐purified cerebrospinal fluid and cerebrospinal fluid‐derived extracellular vesicles from patients with Alzheimer's, Parkinson's and Lewy body dementia. Journal of Extracellular Vesicles. 2023. doi:10.1002/jev2.12383
BibTeX
@article{Hirschberg2023,
author = {Hirschberg, Yael and Valle-Tamayo, Natalia and Dols-Icardo, Oriol and Engelborghs, Sebastiaan and Buelens, Bart and Vandenbroucke, Roosmarijn E and Vermeiren, Yannick and Boonen, Kurt and Mertens, Inge},
title = {Proteomic comparison between non‐purified cerebrospinal fluid and cerebrospinal fluid‐derived extracellular vesicles from patients with Alzheimer's, Parkinson's and Lewy body dementia},
journal = {Journal of Extracellular Vesicles},
year = {2023},
doi = {10.1002/jev2.12383}
}
EUVIMED